The 1st Psoriasis Symposium, organised by the Psoriasis Association of Bosnia and Herzegovina in collaboration with the Skin Inflammation & Psoriasis International Network (SPIN), the International Society of Dermatology and the European Academy of Dermatology and Venerology, was held in Sarajevo on 13-15 October 2017.
The Symposium was intended to provide delegates with the latest research and facts on diagnoses and genetics of psoriasis and psoriatic arthritis, long-term treatment with available therapies and treatments in development.
Approximately 200 participants and 40 guests from 22 countries across three continents participated in the Symposium.
The Symposium’s scientific programme included lectures by 26 international invited speakers, with the aim of presenting contemporary achievements in psoriasis and exchanging experiences.
There were 46 lectures and 21 poster presentations as well as 5 sponsored satellite symposia.
The main topics of the Symposium were:
- Immune system and psoriatic disease
- Psoriasis as a systemic disease
- Psoriasis in childhood and pregnancy
- Clinical and diagnostic characteristics of psoriasis and psoriatic arthritis
- Psoriasis therapy: from conventional therapies to biological drugs
- Free themes
As a partner organization, SPIN organized a session during this meeting.
Following the welcome and introductory speeches of SPIN Chair Professor Jo Lambert, lectures were held by the members of the SPIN Scientific Committee:
- Prof. Nejib Doss, Tunisia: Nail psoriasis: differential diagnosis
- Prof. Christopher Griffiths, UK: Systems medicine and psoriasis management
- Prof. Romana Ceovoc, Croatia: Topical treatments and phototherapy in the era of biologics
- Prof. Thomas A. Luger, Germany: Novel therapies for psoriasis: where are we going?
- Prof. Jo Lambert, Belgium: Tailored prescribing of biologicals: a challenge for the near future.
That event was also marked by the celebration of World Psoriasis Day - a day for awareness and advocacy for all people living with psoriasis and psoriatic arthritis around the world!
Rich cultural and social programs and the unique multicultural spirit and historical heritage of Sarajevo city have contributed to the good mood of all participants wishing to meet again and to exchange some new experiences.
SPIN Presentation
Recent news
- 2019/04/18 Focus on...
- 2019/04/17 Focus on...
- 2018/07/16 Focus on...
- 2018/07/09 Focus on...
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Moderate-to-severe psoriasis and pregnancy: impact on fertility, pregnancy outcome and treatment perspectives.
G Ital Dermatol Venereol.
2019 Jun , 154, (3):305-314.
Psoriasis affects 2-4% of the world's population, with no difference between men and women and 70% of patients experiencing disease onset before the age of 40, which coincides with the reproductive years. Few data are available from literature on impact of psoriasis on fertility, course and outcome of pregnancy and risk associated with treatments. Recent studies on other immune-mediated inflammatory diseases, among which psoriasis is also included, indicate that rheumatoid arthritis and (...)
see on pubmed
Squamous cell carcinoma-related antigen 2 level is a reliable indicator of severe psoriasis involving the face.
G Ital Dermatol Venereol.
2019 Jun , 154, (3):374-375.
Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis.
J. Cell. Physiol..
2019 Jul , 234, (7):9943-9955.
Dimethyl fumarate (DMF) is an important oral treatment option for various autoimmune diseases, such as multiple sclerosis (MS) and psoriasis. DMF and its dynamic metabolite, monomethyl fumarate (MMF) are the major compounds that exert therapeutic effects on several pathologic conditions in part, through downregulation of immune responses. The exact mechanism of DMF is yet to be fully understood even though its beneficial effects on the immune system are extensively studied. It has been (...)
see on pubmed
on Atopic Dermatitis
Silver nanoparticles assessment in moisturizing creams by ultrasound assisted extraction followed by sp-ICP-MS.
Talanta.
2019 May 15, 197:530-538.
Advances on nanometrology require reliable sample pre-treatment methods for extracting/isolating nanomaterials from complex samples. The current development deals with a discontinuous ultrasonication (60% amplitude, 15 cycles of ultrasound treatment for 59 s plus relaxing stage for 59 s, 20 mL of methanol) method for a fast and quantitative extraction of silver nanoparticles (Ag NPs) from moisturizing creams. Possibilities offered by modern inductively coupled plasma mass spectrometry (ICP-MS) (...)
see on pubmed
Should we treat every infant with a probiotic?
Underwood MA.
Should we treat every infant with a probiotic?
Minerva Pediatr..
2019 Jun , 71, (3):253-262.
Intestinal dysbiosis is associated with a long list of both acute and chronic inflammatory diseases and appears to be increasing in developed countries over the last century with the introduction of antibiotics, changes in sanitation, formula feeding and cesarean sections. The evidence supporting prophylactic administration of probiotic microbes to very preterm infants for the prevention of necrotizing enterocolitis, late onset sepsis and death is strong. The evidence for benefit of (...)
see on pubmed
Effect of cinnamamides on atopic dermatitis through regulation of IL-4 in CD4 cells.
Choi EJ et al.
Effect of cinnamamides on atopic dermatitis through regulation of IL-4 in CD4 cells.
J Enzyme Inhib Med Chem.
2019 Dec , 34, (1):613-619.
This study aimed to evaluate the effects of cinnamamides on atopic dermatitis (AD) and the mechanisms underlying these effects. To this end, the actions of two cinnamamides, (E)-3-(4-hydroxyphenyl)-N-phenylethyl acrylamide (NCT) and N-trans-coumaroyltyramine (NCPA), were determined on AD by orally administering them to mice. Oral administration of the cinnamamides ameliorated the increase in epidermal and dermal thickness as well as mast cell infiltration. Cinnamamides suppressed serum (...)
see on pubmed
